Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRX-115 With and Without Methotrexate in Adult Patients With Gout
NCT07280156Phase 2Recruiting
- Sponsor
- Protalix BioTherapeutics
- Start
- Dec 2025
- Primary completion
- Dec 2027
- Modality
- Replacement Enzymes
- Countries
- 3
01
Overview
A Phase 2 trial of prx-115 in gout, sponsored by Protalix BioTherapeutics. Started Dec 2025; status: recruiting.
02
Drugs
prx-115
03
Conditions
gout
Beyond the preview
Go deeper on NCT07280156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07280156.